MorphoSys Says Roche To Start Phase 3 Gantenerumab Trials In Alzheimer's Disease

6. März 2017 INDIZES USA

(RTTNews) – MorphoSys AG (MPSYY.PK) Monday announced that its partner Roche plans to initiate a new pivotal phase 3 program for …
(Orginal – Story lesen…)

Tags: dow jones nasdaq s&p 500

You may also like...